Akoya Biosciences Operating Margin vs. Return On Asset

AKYA Stock  USD 2.71  0.01  0.37%   
Based on Akoya Biosciences' profitability indicators, Akoya Biosciences may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in October. Profitability indicators assess Akoya Biosciences' ability to earn profits and add value for shareholders.

Akoya Biosciences Operating Profit Margin

(0.61)

At present, Akoya Biosciences' Days Sales Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Days Of Sales Outstanding is expected to grow to 75.64, whereas Price To Sales Ratio is forecasted to decline to 2.13. At present, Akoya Biosciences' Income Tax Expense is projected to decrease significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 3.3 M, whereas Accumulated Other Comprehensive Income is forecasted to decline to (5.7 K).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.640.4992
Significantly Up
Very volatile
For Akoya Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Akoya Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Akoya Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Akoya Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Akoya Biosciences over time as well as its relative position and ranking within its peers.
  

Akoya Biosciences' Revenue Breakdown by Earning Segment

Check out Trending Equities.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akoya Biosciences. If investors know Akoya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akoya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.17)
Revenue Per Share
1.889
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.18)
Return On Equity
(1.28)
The market value of Akoya Biosciences is measured differently than its book value, which is the value of Akoya that is recorded on the company's balance sheet. Investors also form their own opinion of Akoya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Akoya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akoya Biosciences' market value can be influenced by many factors that don't directly affect Akoya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akoya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akoya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akoya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Akoya Biosciences Return On Asset vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Akoya Biosciences's current stock value. Our valuation model uses many indicators to compare Akoya Biosciences value to that of its competitors to determine the firm's financial worth.
Akoya Biosciences is rated below average in operating margin category among its peers. It also is rated below average in return on asset category among its peers . At present, Akoya Biosciences' Operating Profit Margin is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akoya Biosciences' earnings, one of the primary drivers of an investment's value.

Akoya Biosciences' Earnings Breakdown by Geography

Akoya Return On Asset vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Akoya Biosciences

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
(0.47) %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Akoya Biosciences

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.18
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Akoya Return On Asset Comparison

Akoya Biosciences is currently under evaluation in return on asset category among its peers.

Akoya Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Akoya Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Akoya Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Akoya Biosciences' change in net profit over the period of time. It can combine multiple indicators of Akoya Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-5.4 K-5.7 K
Net Interest Income-5.2 M-5.4 M
Operating Income-56 M-58.8 M
Net Loss-71.4 M-67.8 M
Income Before Tax-63.3 M-66.4 M
Total Other Income Expense Net-7.3 M-7.6 M
Net Loss-63.6 M-60.4 M
Net Loss-63.3 M-66.5 M
Income Tax Expense40 K41.4 K
Interest Income3.1 M3.3 M
Non Operating Income Net Other163.3 K171.5 K
Change To Netincome8.6 M4.6 M
Net Loss(1.43)(1.50)
Income Quality 0.80  0.60 
Net Income Per E B T 1.00  1.10 

Akoya Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Akoya Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Akoya Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Akoya Biosciences' important profitability drivers and their relationship over time.

Use Akoya Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akoya Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will appreciate offsetting losses from the drop in the long position's value.

Akoya Biosciences Pair Trading

Akoya Biosciences Pair Trading Analysis

The ability to find closely correlated positions to Akoya Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akoya Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akoya Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akoya Biosciences to buy it.
The correlation of Akoya Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akoya Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akoya Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akoya Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Akoya Biosciences position

In addition to having Akoya Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Emerging Markets ETFs Thematic Idea Now

Emerging Markets ETFs
Emerging Markets ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Emerging Markets ETFs theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Akoya Stock

When determining whether Akoya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akoya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akoya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akoya Biosciences Stock:
Check out Trending Equities.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
To fully project Akoya Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Akoya Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Akoya Biosciences' income statement, its balance sheet, and the statement of cash flows.
Potential Akoya Biosciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Akoya Biosciences investors may work on each financial statement separately, they are all related. The changes in Akoya Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Akoya Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.